Resources Contact Us Home
Assay for methylation in the GST-Pi gene

Image Number 10 for United States Patent #8088577.

A diagnostic or prognostic assay is disclosed for a disease of condition characterized by abnormal methylation of cytosine at side or sites within the glutathione-S-transferase (GST) Pi gene and/or its regulatory flanking sequences (e.g., prostate cancer and liver cancer). The assay comprises: (i) isolating DNA from said subject, and (ii) determining (e.g., by selective PCR amplification) the presence of abnormal methylation of cytosine at a site or sites within the GST-Pi gene and/or its regulatory flanking sequences.

  Recently Added Patents
Method for producing a flexible composite elastomeric polyurethane skin
Optical modulator module
Recombinant negative strand virus RNA expression systems and vaccines
Multi user MIMO detection utilizing averaged spatial whitening
Potato cultivar F10
Method and apparatus for linking a web browser link to a promotional offer
Methods and devices for rapid and specific detection of multiple proteins
  Randomly Featured Patents
Method and substrate composition for treating atherosclerosis
Objective lens element and optical head device including the same
Wireless communication system and lift system having the same
Simplified sound reproducing device capable of reproducing a plurality of recorded items
Catadioptric reduction lens
Display system
Fuel injection control method for a direct injection gaseous-fuelled internal combustion engine
Method and system for diagnosing a drivetrain during shifting operations
Devices and methods for dynamic fixation of skeletal structure
Method and apparatus for displaying prioritized icons in a mobile terminal